Newsroom
May 25, 2023
From social media to ads featuring an earworm jingle, it’s hard to escape hearing about Ozempic. Hailed for its game-changing effect on diabetes and obesity, semaglutide, the generic medication sold under the brand name Ozempic, is now being studied for its effectiveness on another deadly disease — Alzheimer’s. The Glenn Biggs Institute for Alzheimer’s and […]
May 18, 2023
Sudha Seshadri, MD, professor, Neurology, founding director, Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, was quoted in this story. Read More
May 18, 2023
UT Health San Antonio President William L. Henrich, MD, MACP, was quoted in this article. Read Now
May 5, 2023
The University of Texas Health Science Center at San Antonio has appointed Elena Volpi, MD, PhD, FGSA, as director of its Sam and Ann Barshop Institute for Longevity and Aging Studies. She will also be a professor in the Department of Medicine effective July 1, said Robert Hromas, MD, dean of the health science […]
May 5, 2023
The start of the construction on the Center for Brain Health was featured in this piece. Read More
May 4, 2023
Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu SAN ANTONIO (May 4, 2023) — The University of Texas Health Science Center at San Antonio has appointed Elena Volpi, MD, PhD, FGSA, as director of its Sam and Ann Barshop Institute for Longevity and Aging Studies. She will also be a professor in the Department of Medicine effective July […]
